This country profile provides an overview of Guinea-Bissau’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
73%
Blinding trachoma
85%
Intestinal worms
62%
Bilharzia
0%
River blindness
78%
1.04 million people received treatment in Guinea-Bissau in 2017 0.3 million people did not receive treatment in Guinea-Bissau in 2017

Priorities for progress in Guinea-Bissau

  • Guinea-Bissau is commended for the progress made in the last two years in increasing coverage for elephantiasis and river blindness.
  • As a priority, it should work to fully integrate treatment across all the five NTDs, with systematically high annual coverage for all the components, in all risk groups, as recommended by WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage was not reported in 2016 and 73% in 2017.

People needing treatment
1.13m
People receiving treatment
0.83m

Blinding trachoma

Treatment coverage decreased from 88% in 2016 to 85% in 2017.

People needing treatment
0.41m
People receiving treatment
0.35m

Intestinal worms

Treatment coverage increased from 33% in 2016 to 62% in 2017.

Pre-sch and school-aged children needing treatment
0.69m
Pre-school and school-aged children receiving treatment
0.42m

Bilharzia

Treatment coverage stayed at 0% from 2016 to 2017.

School-aged children needing treatment
0.21m
School-aged children receiving treatment
0m

River blindness

 Treatment coverage was not reported in 2016 and 78% in 2017.

People needing treatment
0.55m
People receiving treatment
0.43m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Guinea-Bissau.